Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (970)
- (1)
- (23,543)
- (5)
- (1)
- (1)
- (67)
- (219)
- (4,424)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,461)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (254)
- (22,606)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,166)
- (256)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (108)
- (1)
- (3,782)
- (1,408)
- (3)
- (4)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (3)
- (18)
- (48)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (191)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,728)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (25,926)
- (240)
- (1)
- (3)
Recombinant
- (286)
- (2)
- (61,741)
- (1)
Form
- (15)
- (1)
- (2)
- (45,213)
- (5,693)
- (245)
- (168)
- (56)
- (3,364)
Species
- (2)
- (1)
- (2)
- (1)
- (21)
- (558)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,042)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (26,017)
- (5)
- (1)
- (4)
- (582)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (120)
- (9)
- (2)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (6)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (38,945)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
4,951
–
4,965
of
115,752
results
R&D Systems™ Recombinant Human RELT/TNFRSF19L Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human Reg4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
| Purity or Quality Grade | >95% by reducing SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.2 |
| Form | Liquid |
| Common Name | SARS-CoV-2 Spike Protein S1/S2 |
| Storage Requirements | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Sequence | SARS-CoV-2 Spike Protein S1+S2, amino acids 14-1213 (s-ECD region) |
| Concentration | 1.5 mg/mL |
| Expression System | E. coli |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein (S1/S2) (aa14-1213), His Tag |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.2 |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 24.76 kDa |
| Formulation | 10 mM tris HCl with 50% glycerol, 62.5 mM NaCl and no preservative; pH 8 |
| Sequence | Amino acids Ala21-Arg200 containing an N-terminal His-tag |
| Concentration | 0.25 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human TREM-1 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥90% as determined by SDS-PAGE. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Liquid |
| Common Name | SARS-CoV-2 Spike Protein S1/S2 |
| Activity | ED50 = 0.15-9.92 ng/mL; determined by the binding of immobilized SARS-CoV-2 Spike Protein S1+S2 recombinant protein (2 μg/mL) to human ACE2 recombinant protein in a functional ELISA. |
| Endotoxin Concentration | <0.1 EU/μg |
| Storage Requirements | -80°C |
| Sequence | SARS-CoV-2 Spike Protein S1+S2, amino acids Val11-Gln1208 (Accession # YP_009724390.1) (s-ECD region) with a C-terminal His-tag |
| Concentration | 0.65 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein S1/S2 (aa11-1208), His Tag |
| Regulatory Status | RUO |
| Purification Method | SDS-PAGE |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | ≥90% as determined by SDS-PAGE. ≥85% as determined by SEC-HPLC. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD79a/CD79b |
| Molecular Weight (g/mol) | 37.47 kDa |
| Gene Symbol | CD79A, CD79B |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human CD79A, amino acids Met1-Arg143 (Accession # NP_001774.1) with a C-terminal Flag-tag and human CD78B, amino acids Met1-Asp159 (Accession # NP_000617.1) with a C-terminal His-tag were co-expressed and purified as a human CD79A & CD79B heterodimer |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,Neutralization |
| Name | Human CD79 (CD79a/CD79b Heterodimer) His-Flag Tag |
| Accession Number | P11912, P40259 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Format | Lyophilized |
| Product Type | Protein |
| Gene ID (Entrez) | 973, 974 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | DYKDDDDK-tag, His-tag |
| Recombinant | Recombinant |
Novus Biologicals™ Recombinant E. coli Thioredoxin Reductase 1/TRXR1 Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified and high bioactivity. Generating reliable and reproducible results.
Novus Biologicals™ Recombinant Human ERGI3 His Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | C20orf47, CGI-54, chromosome 20 open reading frame 47, dJ477O4.2, endoplasmic reticulum-Golgi intermediate compartment protein 3, endoplasmic reticulum-localized protein ERp43, ERGIC and golgi 3, Erv46, NY-BR-84, PRO0989, SDBCAG84, serologically defined breast cancer antigen 84, Serologically defined breast cancer antigen NY-BR-84 |
| Common Name | ERGI3 |
| Molecular Weight (g/mol) | TMW: 36.1kDa |
| Gene ID (Entrez) | 51614 |
| Formulation | PBS buffer (pH 7.4) containing 10% glycerol, 1mM DTT |
| Storage Requirements | Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles. |
| Concentration | 1mg/mL |
| For Use With (Application) | SDS-PAGE |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human Survivin Western Blot Standard Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Western Blot
MilliporeSigma™ Calbiochem™ Endothelial Cell Growth Supplement, Bovine Neural Tissue
Used in screening for contamination by bacteria, fungi, and mycoplasm
| Purity or Quality Grade | >95%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 14 kDa, reducing conditions 24 kDa, non-reducing conditions; M.W. (theoretical): 13 kDa (monomer) |
| Gene Symbol | INHBA |
| Quantity | 500 μg |
| Endotoxin Concentration | <0.01 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | Activin A |
| Source | Chinese Hamster Ovary cell line, CHO-derived Activin A protein Gly311-Ser426 |
| Accession Number | P08476 |
| Regulatory Status | RUO |
| Product Type | Recombinant protein |
| Biological Activity | 0.2 to 1.2ng/mL |
| Gene ID (Entrez) | 3624 |
| Reconstitution | Reconstitute at 100-500 μg/mL in sterile 4 mM HCl. |
| Species | Human,Mouse,Rat |
| Recombinant | Recombinant |